Previous
FDA Guidance for Clinical Investigators, Sponsors and IRBs Regarding Adverse Event Reporting in GCP Regulated Environments
FDA Guidance for Clinical Investigators, Sponsors and IRBs Regarding Adverse Event Reporting in GCP Regulated Environments

This white paper examines the key points of the guidance and the thinking behind the FDA’s 2009 “Guidance f...

Next Flipbook
CAP Accreditation and Document Control
CAP Accreditation and Document Control

The College of American Pathologists (CAP) outlines the requirements and benefits of CAP accreditation for ...